CNA landscape of HER2-negative breast cancer during administration of taxane-containing schemes of neoadjuvant chemotherapy
Introduction. Evaluation of when and how to include taxanes in preoperative chemotherapy is becoming more important in the era when molecular and genetic approaches allow to develop biologically targeted therapeutic medications and select patients who can benefit from certain cytotoxic agents.Aim. T...
Saved in:
| Main Authors: | M. K. Ibragimova, E. A. Kravtsova, M. M. Tsyganov, N. V. Litviakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2025-04-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/757 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
by: M. K. Ibragimova, et al.
Published: (2020-10-01) -
ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
by: N. V. Litviakov, et al.
Published: (2020-07-01) -
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01) -
Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine
by: Bilgin Demir, et al.
Published: (2025-08-01) -
Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab
by: Toshihiko Matsumoto, et al.
Published: (2025-08-01)